Industry Research Reports

Home > Reports > Medical Care > Global Diabetes Therapeutics and Diagnostics Market Research Report 2024

Global Diabetes Therapeutics and Diagnostics Market Research Report 2024

Industry: Medical Care

Published Date: 2024-01-16

Pages: 108 Pages

Report ld: 2237208

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Diabetes Therapeutics and Diagnostics Market Size(US$)

CAGR 2024-2030

2.5%

Market Size,2030

USD 143,500

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 123,740 million

Market Forecast in 2030(Value)

US$ 143,500 million

CAGR

2.5%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.

The global Diabetes Therapeutics and Diagnostics market was valued at US$ 117140 million in 2023 and is anticipated to reach US$ 143500 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Diabetes Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Therapeutics and Diagnostics.

MARKET SEGMENTATION

By Company

77 Elektronika Kft.
A. Menarini Diagnostics S.R.L
Abbott Laboratories
Agamatrix Inc.
Animas Corp.
Ascensia
Becton Dickinson
Debiotech S.A.
Eli Lilly And Co.
Glaxo Smithkline
Inlight Solutions Inc.
Johnson & Johnson
Lifescan Inc.
Medtronic
Merck & Co.
Merck KGAA
Nipro Corp.
Novartis Pharma Ag
Novo Nordisk A/S
Owen Mumford Ltd.
Palco Labs Inc.
Roche
Sanofi
Takeda Pharmaceutical Co. Ltd.
Terumo Corp.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Insulin
Insulin Delivery
Oral Hypoglycemic Drugs
Diagnosis And Monitoring
Others

Segment by Application

Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Others

biaoTi REPORT SCOPE

The Diabetes Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Therapeutics and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diabetes Therapeutics and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Diabetes Therapeutics and Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Insulin

1.2.3 Insulin Delivery

1.2.4 Oral Hypoglycemic Drugs

1.2.5 Diagnosis And Monitoring

1.2.6 Others

1.3 Market by Application

1.3.1 Global Diabetes Therapeutics and Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Type 1 Diabetes

1.3.3 Type 2 Diabetes

1.3.4 Gestational Diabetes

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diabetes Therapeutics and Diagnostics Market Perspective (2019-2030)

2.2 Diabetes Therapeutics and Diagnostics Growth Trends by Region

2.2.1 Global Diabetes Therapeutics and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Diabetes Therapeutics and Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Diabetes Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Diabetes Therapeutics and Diagnostics Market Dynamics

2.3.1 Diabetes Therapeutics and Diagnostics Industry Trends

2.3.2 Diabetes Therapeutics and Diagnostics Market Drivers

2.3.3 Diabetes Therapeutics and Diagnostics Market Challenges

2.3.4 Diabetes Therapeutics and Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Diabetes Therapeutics and Diagnostics Players by Revenue

3.1.1 Global Top Diabetes Therapeutics and Diagnostics Players by Revenue (2019-2024)

3.1.2 Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Diabetes Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Diabetes Therapeutics and Diagnostics Revenue

3.4 Global Diabetes Therapeutics and Diagnostics Market Concentration Ratio

3.4.1 Global Diabetes Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diabetes Therapeutics and Diagnostics Revenue in 2023

3.5 Diabetes Therapeutics and Diagnostics Key Players Head office and Area Served

3.6 Key Players Diabetes Therapeutics and Diagnostics Product Solution and Service

3.7 Date of Enter into Diabetes Therapeutics and Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetes Therapeutics and Diagnostics Breakdown Data by Type

4.1 Global Diabetes Therapeutics and Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030)

5 Diabetes Therapeutics and Diagnostics Breakdown Data by Application

5.1 Global Diabetes Therapeutics and Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Diabetes Therapeutics and Diagnostics Market Size (2019-2030)

6.2 North America Diabetes Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024)

6.4 North America Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Diabetes Therapeutics and Diagnostics Market Size (2019-2030)

7.2 Europe Diabetes Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024)

7.4 Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Diabetes Therapeutics and Diagnostics Market Size (2019-2030)

9.2 Latin America Diabetes Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024)

9.4 Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 77 Elektronika Kft.

11.1.1 77 Elektronika Kft. Company Detail

11.1.2 77 Elektronika Kft. Business Overview

11.1.3 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Introduction

11.1.4 77 Elektronika Kft. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.1.5 77 Elektronika Kft. Recent Development

11.2 A. Menarini Diagnostics S.R.L

11.2.1 A. Menarini Diagnostics S.R.L Company Detail

11.2.2 A. Menarini Diagnostics S.R.L Business Overview

11.2.3 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Introduction

11.2.4 A. Menarini Diagnostics S.R.L Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.2.5 A. Menarini Diagnostics S.R.L Recent Development

11.3 Abbott Laboratories

11.3.1 Abbott Laboratories Company Detail

11.3.2 Abbott Laboratories Business Overview

11.3.3 Abbott Laboratories Diabetes Therapeutics and Diagnostics Introduction

11.3.4 Abbott Laboratories Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.3.5 Abbott Laboratories Recent Development

11.4 Agamatrix Inc.

11.4.1 Agamatrix Inc. Company Detail

11.4.2 Agamatrix Inc. Business Overview

11.4.3 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Introduction

11.4.4 Agamatrix Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.4.5 Agamatrix Inc. Recent Development

11.5 Animas Corp.

11.5.1 Animas Corp. Company Detail

11.5.2 Animas Corp. Business Overview

11.5.3 Animas Corp. Diabetes Therapeutics and Diagnostics Introduction

11.5.4 Animas Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.5.5 Animas Corp. Recent Development

11.6 Ascensia

11.6.1 Ascensia Company Detail

11.6.2 Ascensia Business Overview

11.6.3 Ascensia Diabetes Therapeutics and Diagnostics Introduction

11.6.4 Ascensia Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.6.5 Ascensia Recent Development

11.7 Becton Dickinson

11.7.1 Becton Dickinson Company Detail

11.7.2 Becton Dickinson Business Overview

11.7.3 Becton Dickinson Diabetes Therapeutics and Diagnostics Introduction

11.7.4 Becton Dickinson Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.7.5 Becton Dickinson Recent Development

11.8 Debiotech S.A.

11.8.1 Debiotech S.A. Company Detail

11.8.2 Debiotech S.A. Business Overview

11.8.3 Debiotech S.A. Diabetes Therapeutics and Diagnostics Introduction

11.8.4 Debiotech S.A. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.8.5 Debiotech S.A. Recent Development

11.9 Eli Lilly And Co.

11.9.1 Eli Lilly And Co. Company Detail

11.9.2 Eli Lilly And Co. Business Overview

11.9.3 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Introduction

11.9.4 Eli Lilly And Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.9.5 Eli Lilly And Co. Recent Development

11.10 Glaxo Smithkline

11.10.1 Glaxo Smithkline Company Detail

11.10.2 Glaxo Smithkline Business Overview

11.10.3 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Introduction

11.10.4 Glaxo Smithkline Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.10.5 Glaxo Smithkline Recent Development

11.11 Inlight Solutions Inc.

11.11.1 Inlight Solutions Inc. Company Detail

11.11.2 Inlight Solutions Inc. Business Overview

11.11.3 Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Introduction

11.11.4 Inlight Solutions Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.11.5 Inlight Solutions Inc. Recent Development

11.12 Johnson & Johnson

11.12.1 Johnson & Johnson Company Detail

11.12.2 Johnson & Johnson Business Overview

11.12.3 Johnson & Johnson Diabetes Therapeutics and Diagnostics Introduction

11.12.4 Johnson & Johnson Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.12.5 Johnson & Johnson Recent Development

11.13 Lifescan Inc.

11.13.1 Lifescan Inc. Company Detail

11.13.2 Lifescan Inc. Business Overview

11.13.3 Lifescan Inc. Diabetes Therapeutics and Diagnostics Introduction

11.13.4 Lifescan Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.13.5 Lifescan Inc. Recent Development

11.14 Medtronic

11.14.1 Medtronic Company Detail

11.14.2 Medtronic Business Overview

11.14.3 Medtronic Diabetes Therapeutics and Diagnostics Introduction

11.14.4 Medtronic Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.14.5 Medtronic Recent Development

11.15 Merck & Co.

11.15.1 Merck & Co. Company Detail

11.15.2 Merck & Co. Business Overview

11.15.3 Merck & Co. Diabetes Therapeutics and Diagnostics Introduction

11.15.4 Merck & Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.15.5 Merck & Co. Recent Development

11.16 Merck KGAA

11.16.1 Merck KGAA Company Detail

11.16.2 Merck KGAA Business Overview

11.16.3 Merck KGAA Diabetes Therapeutics and Diagnostics Introduction

11.16.4 Merck KGAA Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.16.5 Merck KGAA Recent Development

11.17 Nipro Corp.

11.17.1 Nipro Corp. Company Detail

11.17.2 Nipro Corp. Business Overview

11.17.3 Nipro Corp. Diabetes Therapeutics and Diagnostics Introduction

11.17.4 Nipro Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.17.5 Nipro Corp. Recent Development

11.18 Novartis Pharma Ag

11.18.1 Novartis Pharma Ag Company Detail

11.18.2 Novartis Pharma Ag Business Overview

11.18.3 Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Introduction

11.18.4 Novartis Pharma Ag Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.18.5 Novartis Pharma Ag Recent Development

11.19 Novo Nordisk A/S

11.19.1 Novo Nordisk A/S Company Detail

11.19.2 Novo Nordisk A/S Business Overview

11.19.3 Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Introduction

11.19.4 Novo Nordisk A/S Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.19.5 Novo Nordisk A/S Recent Development

11.20 Owen Mumford Ltd.

11.20.1 Owen Mumford Ltd. Company Detail

11.20.2 Owen Mumford Ltd. Business Overview

11.20.3 Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Introduction

11.20.4 Owen Mumford Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.20.5 Owen Mumford Ltd. Recent Development

11.21 Palco Labs Inc.

11.21.1 Palco Labs Inc. Company Detail

11.21.2 Palco Labs Inc. Business Overview

11.21.3 Palco Labs Inc. Diabetes Therapeutics and Diagnostics Introduction

11.21.4 Palco Labs Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.21.5 Palco Labs Inc. Recent Development

11.22 Roche

11.22.1 Roche Company Detail

11.22.2 Roche Business Overview

11.22.3 Roche Diabetes Therapeutics and Diagnostics Introduction

11.22.4 Roche Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.22.5 Roche Recent Development

11.23 Sanofi

11.23.1 Sanofi Company Detail

11.23.2 Sanofi Business Overview

11.23.3 Sanofi Diabetes Therapeutics and Diagnostics Introduction

11.23.4 Sanofi Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.23.5 Sanofi Recent Development

11.24 Takeda Pharmaceutical Co. Ltd.

11.24.1 Takeda Pharmaceutical Co. Ltd. Company Detail

11.24.2 Takeda Pharmaceutical Co. Ltd. Business Overview

11.24.3 Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Introduction

11.24.4 Takeda Pharmaceutical Co. Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.24.5 Takeda Pharmaceutical Co. Ltd. Recent Development

11.25 Terumo Corp.

11.25.1 Terumo Corp. Company Detail

11.25.2 Terumo Corp. Business Overview

11.25.3 Terumo Corp. Diabetes Therapeutics and Diagnostics Introduction

11.25.4 Terumo Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)

11.25.5 Terumo Corp. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Insulin

Table 3. Key Players of Insulin Delivery

Table 4. Key Players of Oral Hypoglycemic Drugs

Table 5. Key Players of Diagnosis And Monitoring

Table 6. Key Players of Others

Table 7. Global Diabetes Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Diabetes Therapeutics and Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Diabetes Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Diabetes Therapeutics and Diagnostics Market Share by Region (2019-2024)

Table 11. Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Diabetes Therapeutics and Diagnostics Market Share by Region (2025-2030)

Table 13. Diabetes Therapeutics and Diagnostics Market Trends

Table 14. Diabetes Therapeutics and Diagnostics Market Drivers

Table 15. Diabetes Therapeutics and Diagnostics Market Challenges

Table 16. Diabetes Therapeutics and Diagnostics Market Restraints

Table 17. Global Diabetes Therapeutics and Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Diabetes Therapeutics and Diagnostics Market Share by Players (2019-2024)

Table 19. Global Top Diabetes Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Therapeutics and Diagnostics as of 2023)

Table 20. Ranking of Global Top Diabetes Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Diabetes Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Diabetes Therapeutics and Diagnostics Product Solution and Service

Table 24. Date of Enter into Diabetes Therapeutics and Diagnostics Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Diabetes Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Type (2019-2024)

Table 28. Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Type (2025-2030)

Table 30. Global Diabetes Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Application (2019-2024)

Table 32. Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Application (2025-2030)

Table 34. North America Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 49. 77 Elektronika Kft. Company Detail

Table 50. 77 Elektronika Kft. Business Overview

Table 51. 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Product

Table 52. 77 Elektronika Kft. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 53. 77 Elektronika Kft. Recent Development

Table 54. A. Menarini Diagnostics S.R.L Company Detail

Table 55. A. Menarini Diagnostics S.R.L Business Overview

Table 56. A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Product

Table 57. A. Menarini Diagnostics S.R.L Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 58. A. Menarini Diagnostics S.R.L Recent Development

Table 59. Abbott Laboratories Company Detail

Table 60. Abbott Laboratories Business Overview

Table 61. Abbott Laboratories Diabetes Therapeutics and Diagnostics Product

Table 62. Abbott Laboratories Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 63. Abbott Laboratories Recent Development

Table 64. Agamatrix Inc. Company Detail

Table 65. Agamatrix Inc. Business Overview

Table 66. Agamatrix Inc. Diabetes Therapeutics and Diagnostics Product

Table 67. Agamatrix Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 68. Agamatrix Inc. Recent Development

Table 69. Animas Corp. Company Detail

Table 70. Animas Corp. Business Overview

Table 71. Animas Corp. Diabetes Therapeutics and Diagnostics Product

Table 72. Animas Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 73. Animas Corp. Recent Development

Table 74. Ascensia Company Detail

Table 75. Ascensia Business Overview

Table 76. Ascensia Diabetes Therapeutics and Diagnostics Product

Table 77. Ascensia Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 78. Ascensia Recent Development

Table 79. Becton Dickinson Company Detail

Table 80. Becton Dickinson Business Overview

Table 81. Becton Dickinson Diabetes Therapeutics and Diagnostics Product

Table 82. Becton Dickinson Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 83. Becton Dickinson Recent Development

Table 84. Debiotech S.A. Company Detail

Table 85. Debiotech S.A. Business Overview

Table 86. Debiotech S.A. Diabetes Therapeutics and Diagnostics Product

Table 87. Debiotech S.A. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 88. Debiotech S.A. Recent Development

Table 89. Eli Lilly And Co. Company Detail

Table 90. Eli Lilly And Co. Business Overview

Table 91. Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Product

Table 92. Eli Lilly And Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 93. Eli Lilly And Co. Recent Development

Table 94. Glaxo Smithkline Company Detail

Table 95. Glaxo Smithkline Business Overview

Table 96. Glaxo Smithkline Diabetes Therapeutics and Diagnostics Product

Table 97. Glaxo Smithkline Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 98. Glaxo Smithkline Recent Development

Table 99. Inlight Solutions Inc. Company Detail

Table 100. Inlight Solutions Inc. Business Overview

Table 101. Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Product

Table 102. Inlight Solutions Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 103. Inlight Solutions Inc. Recent Development

Table 104. Johnson & Johnson Company Detail

Table 105. Johnson & Johnson Business Overview

Table 106. Johnson & Johnson Diabetes Therapeutics and Diagnostics Product

Table 107. Johnson & Johnson Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 108. Johnson & Johnson Recent Development

Table 109. Lifescan Inc. Company Detail

Table 110. Lifescan Inc. Business Overview

Table 111. Lifescan Inc. Diabetes Therapeutics and Diagnostics Product

Table 112. Lifescan Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 113. Lifescan Inc. Recent Development

Table 114. Medtronic Company Detail

Table 115. Medtronic Business Overview

Table 116. Medtronic Diabetes Therapeutics and Diagnostics Product

Table 117. Medtronic Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 118. Medtronic Recent Development

Table 119. Merck & Co. Company Detail

Table 120. Merck & Co. Business Overview

Table 121. Merck & Co. Diabetes Therapeutics and Diagnostics Product

Table 122. Merck & Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 123. Merck & Co. Recent Development

Table 124. Merck KGAA Company Detail

Table 125. Merck KGAA Business Overview

Table 126. Merck KGAA Diabetes Therapeutics and Diagnostics Product

Table 127. Merck KGAA Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 128. Merck KGAA Recent Development

Table 129. Nipro Corp. Company Detail

Table 130. Nipro Corp. Business Overview

Table 131. Nipro Corp. Diabetes Therapeutics and Diagnostics Product

Table 132. Nipro Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 133. Nipro Corp. Recent Development

Table 134. Novartis Pharma Ag Company Detail

Table 135. Novartis Pharma Ag Business Overview

Table 136. Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Product

Table 137. Novartis Pharma Ag Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 138. Novartis Pharma Ag Recent Development

Table 139. Novo Nordisk A/S Company Detail

Table 140. Novo Nordisk A/S Business Overview

Table 141. Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Product

Table 142. Novo Nordisk A/S Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 143. Novo Nordisk A/S Recent Development

Table 144. Owen Mumford Ltd. Company Detail

Table 145. Owen Mumford Ltd. Business Overview

Table 146. Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Product

Table 147. Owen Mumford Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 148. Owen Mumford Ltd. Recent Development

Table 149. Palco Labs Inc. Company Detail

Table 150. Palco Labs Inc. Business Overview

Table 151. Palco Labs Inc. Diabetes Therapeutics and Diagnostics Product

Table 152. Palco Labs Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 153. Palco Labs Inc. Recent Development

Table 154. Roche Company Detail

Table 155. Roche Business Overview

Table 156. Roche Diabetes Therapeutics and Diagnostics Product

Table 157. Roche Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 158. Roche Recent Development

Table 159. Sanofi Company Detail

Table 160. Sanofi Business Overview

Table 161. Sanofi Diabetes Therapeutics and Diagnostics Product

Table 162. Sanofi Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 163. Sanofi Recent Development

Table 164. Takeda Pharmaceutical Co. Ltd. Company Detail

Table 165. Takeda Pharmaceutical Co. Ltd. Business Overview

Table 166. Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Product

Table 167. Takeda Pharmaceutical Co. Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 168. Takeda Pharmaceutical Co. Ltd. Recent Development

Table 169. Terumo Corp. Company Detail

Table 170. Terumo Corp. Business Overview

Table 171. Terumo Corp. Diabetes Therapeutics and Diagnostics Product

Table 172. Terumo Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 173. Terumo Corp. Recent Development

Table 174. Research Programs/Design for This Report

Table 175. Key Data Information from Secondary Sources

Table 176. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Diabetes Therapeutics and Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Diabetes Therapeutics and Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Insulin Features

Figure 4. Insulin Delivery Features

Figure 5. Oral Hypoglycemic Drugs Features

Figure 6. Diagnosis And Monitoring Features

Figure 7. Others Features

Figure 8. Global Diabetes Therapeutics and Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Diabetes Therapeutics and Diagnostics Market Share by Application: 2023 VS 2030

Figure 10. Type 1 Diabetes Case Studies

Figure 11. Type 2 Diabetes Case Studies

Figure 12. Gestational Diabetes Case Studies

Figure 13. Others Case Studies

Figure 14. Diabetes Therapeutics and Diagnostics Report Years Considered

Figure 15. Global Diabetes Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Diabetes Therapeutics and Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Diabetes Therapeutics and Diagnostics Market Share by Region: 2023 VS 2030

Figure 18. Global Diabetes Therapeutics and Diagnostics Market Share by Players in 2023

Figure 19. Global Top Diabetes Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Therapeutics and Diagnostics as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Diabetes Therapeutics and Diagnostics Revenue in 2023

Figure 21. North America Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Diabetes Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 23. United States Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Diabetes Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 27. Germany Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Share by Region (2019-2030)

Figure 35. China Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Diabetes Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 43. Mexico Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 47. Turkey Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. 77 Elektronika Kft. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 50. A. Menarini Diagnostics S.R.L Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 51. Abbott Laboratories Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 52. Agamatrix Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 53. Animas Corp. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 54. Ascensia Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 55. Becton Dickinson Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 56. Debiotech S.A. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 57. Eli Lilly And Co. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 58. Glaxo Smithkline Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 59. Inlight Solutions Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 60. Johnson & Johnson Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 61. Lifescan Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 62. Medtronic Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 63. Merck & Co. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 64. Merck KGAA Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 65. Nipro Corp. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 66. Novartis Pharma Ag Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 67. Novo Nordisk A/S Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 68. Owen Mumford Ltd. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 69. Palco Labs Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 70. Roche Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 71. Sanofi Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 72. Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 73. Terumo Corp. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Diabetes Therapeutics and Diagnostics market size from 2024 to 2030? zhanKai

The annual compound growth rate of the global Diabetes Therapeutics and Diagnostics market is 2.5% 2024 to 2030.

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Diabetes Therapeutics and Diagnostics market? shouQi

What was the global market size of Diabetes Therapeutics and Diagnostics in 2024? shouQi

What was the global market size of Diabetes Therapeutics and Diagnostics in 2030? shouQi

Related Reports

Diabetes Therapeutics and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetes Therapeutics and Diagnostics was estimated to be worth US$ 129370 million in 2025 and is projected to reach US$ 153410 million, growing at a CAGR of 2.5% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 152
USD 3950.00
(Single User License)
Global Diabetes Therapeutics and Diagnostics Market Research Report 2026
The global Diabetes Therapeutics and Diagnostics market was valued at US$ 129370 million in 2025 and is anticipated to reach US$ 153410 million by 2032, at a CAGR of 2.5% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 144
USD 2900.00
(Single User License)
Global Diabetes Therapeutics and Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetes Therapeutics and Diagnostics market size was US$ 126520 million in 2024 and is forecast to a readjusted size of US$ 150030 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 120
USD 4250.00
(Single User License)
Diabetes Therapeutics and Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetes Therapeutics and Diagnostics was estimated to be worth US$ 126520 million in 2024 and is forecast to a readjusted size of US$ 150030 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 141
USD 3950.00
(Single User License)
Global Diabetes Therapeutics and Diagnostics Market Research Report 2025
The global market for Diabetes Therapeutics and Diagnostics was valued at US$ 126520 million in the year 2024 and is projected to reach a revised size of US$ 150030 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published Date: 2025-02-27
Pages: 108
USD 2900.00
(Single User License)
Global Diabetes Therapeutics and Diagnostics Market Insights, Forecast to 2030
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Published Date: 2024-04-15
Pages: 127
USD 4900.00
(Single User License)
Diabetes Therapeutics and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Published Date: 2024-01-24
Pages: 166
USD 3950.00
(Single User License)

Diabetes Therapeutics and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetes Therapeutics and Diagnostics was estimated to be worth US$ 129370 million in 2025 and is projected to reach US$ 153410 million, growing at a CAGR of 2.5% from 2026 to 2032.
Published: 2026-07-15
Pages: 152
USD 3950.00 (Single User License)
Global Diabetes Therapeutics and Diagnostics Market Research Report 2026
The global Diabetes Therapeutics and Diagnostics market was valued at US$ 129370 million in 2025 and is anticipated to reach US$ 153410 million by 2032, at a CAGR of 2.5% from 2026 to 2032.
Published: 2026-04-28
Pages: 144
USD 2900.00 (Single User License)
Global Diabetes Therapeutics and Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetes Therapeutics and Diagnostics market size was US$ 126520 million in 2024 and is forecast to a readjusted size of US$ 150030 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 120
USD 4250.00 (Single User License)
Diabetes Therapeutics and Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetes Therapeutics and Diagnostics was estimated to be worth US$ 126520 million in 2024 and is forecast to a readjusted size of US$ 150030 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 141
USD 3950.00 (Single User License)
Global Diabetes Therapeutics and Diagnostics Market Research Report 2025
The global market for Diabetes Therapeutics and Diagnostics was valued at US$ 126520 million in the year 2024 and is projected to reach a revised size of US$ 150030 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published: 2025-02-27
Pages: 108
USD 2900.00 (Single User License)
Global Diabetes Therapeutics and Diagnostics Market Insights, Forecast to 2030
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Published: 2024-04-15
Pages: 127
USD 4900.00 (Single User License)
Diabetes Therapeutics and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Published: 2024-01-24
Pages: 166
USD 3950.00 (Single User License)